Chlorogenic acid inhibits NLRP3 inflammasome activation through Nrf2 activation in diabetic nephropathy

Chlorogenic acid inhibits NLRP3 inflammasome activation through Nrf2 activation in diabetic nephropathy

Saved in:

Bibliographic Details
Main Authors:	Liping Bao, Yuhan Gong, Wenji Xu, Jun Dao, Jinjin Rao, Haihui Yang
Format:	Article
Language:	English
Published:	Public Library of Science (PLoS) 2025-01-01
Series:	PLoS ONE
Online Access:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11703029/?tool=EBI
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Methyl Canthin-6-one-2-carboxylate Inhibits the Activation of the NLRP3 Inflammasome in Synovial Macrophages by Upregulating Nrf2 Expression
by: Yuanyuan Chen, et al.
Published: (2025-01-01)

Metabolic Dysfunction in the Regulation of the NLRP3 Inflammasome Activation: A Potential Target for Diabetic Nephropathy
by: Wenli Zhao, et al.
Published: (2022-01-01)

Metformin Ameliorates Ulcerative Colitis Through Inhibiting NLRP3 Inflammasome Activation
by: Cao R, et al.
Published: (2025-02-01)

Apigenin inhibits NLRP3 inflammasome activation in monocytes and macrophages independently of CD38
by: Knut Husø Lauritzen, et al.
Published: (2025-01-01)

Fatty acid synthase inhibition improves hypertension-induced erectile dysfunction by suppressing oxidative stress and NLRP3 inflammasome-dependent pyroptosis through activating the Nrf2/HO-1 pathway
by: Jiaochen Luan, et al.
Published: (2025-01-01)

α-amanitin induces hepatotoxicity via PPAR-γ inhibition and NLRP3 inflammasome activation
by: Haowei Wang, et al.
Published: (2025-01-01)

Verbascoside Inhibits the Activation of NLRP3 Inflammasome and Improves BV-2 Cell Inflammatory Damage
by: Wenjing HUANG, et al.
Published: (2025-02-01)

Puerariae Radix protects against ulcerative colitis in mice by inhibiting NLRP3 inflammasome activation
by: Yu Ga, et al.
Published: (2024-07-01)

IGF2BP2 Regulates the Progression of Alzheimer's Disease Through m6A‐Mediated NLRP3 Inflammasome
by: Wu Jingrui, et al.
Published: (2025-01-01)

Shionone Inhibits Glomerular Fibirosis by Suppressing NLRP3 Related Inflammasome though SESN2-NRF2/HO-1 Pathway
by: Tian Xiao, et al.
Published: (2025-01-01)

NLRP3 Inflammasome Activation Is Involved in Geniposide-Induced Hepatotoxicity
by: Yixuan Liu, et al.
Published: (2025-01-01)

ALDH2 Overexpression Alleviates High Glucose-Induced Cardiotoxicity by Inhibiting NLRP3 Inflammasome Activation
by: Ruiping Cao, et al.
Published: (2019-01-01)

Hydrogen-Rich Saline Inhibits NLRP3 Inflammasome Activation and Attenuates Experimental Acute Pancreatitis in Mice
by: Jian-Dong Ren, et al.
Published: (2014-01-01)

Artificially Cultivated Ophiocordyceps sinensis Alleviates Diabetic Nephropathy and Its Podocyte Injury via Inhibiting P2X7R Expression and NLRP3 Inflammasome Activation
by: Chao Wang, et al.
Published: (2018-01-01)

Corrigendum to “ALDH2 Overexpression Alleviates High Glucose-Induced Cardiotoxicity by Inhibiting NLRP3 Inflammasome Activation”
by: Ruiping Cao, et al.
Published: (2021-01-01)

Baicalein inhibits NLRP3 inflammasome activation and mitigates placental inflammation and oxidative stress in gestational diabetes mellitus
by: Yao Jun, et al.
Published: (2024-12-01)

NLRP3 Inflammasome: Activation and Regulation in Age-Related Macular Degeneration
by: Jiangyuan Gao, et al.
Published: (2015-01-01)

ROS-Mediated NLRP3 Inflammasome Activity Is Essential for Burn-Induced Acute Lung Injury
by: Shichao Han, et al.
Published: (2015-01-01)

Gut microbiota: a novel target for exercise-mediated regulation of NLRP3 inflammasome activation
by: Jun Chen, et al.
Published: (2025-01-01)

Bushen Huoxue formula protects against renal fibrosis and pyroptosis in chronic kidney disease by inhibiting ROS/NLRP3-mediated inflammasome activation
by: Lin Liao, et al.
Published: (2024-12-01)

MCL Plays an Anti-Inflammatory Role in Mycobacterium tuberculosis-Induced Immune Response by Inhibiting NF-κB and NLRP3 Inflammasome Activation
by: Qingwen Zhang, et al.
Published: (2017-01-01)

Chlorogenic Acids Inhibit Adipogenesis: Implications of Wnt/β-Catenin Signaling Pathway
by: Mengting Liu, et al.
Published: (2021-01-01)

Inhibition of the PERK/TXNIP/NLRP3 Axis by Baicalin Reduces NLRP3 Inflammasome-Mediated Pyroptosis in Macrophages Infected with Mycobacterium tuberculosis
by: Yan Fu, et al.
Published: (2021-01-01)

Hydroxysafflor Yellow A Inhibits LPS-Induced NLRP3 Inflammasome Activation via Binding to Xanthine Oxidase in Mouse RAW264.7 Macrophages
by: Xiaolong Xu, et al.
Published: (2016-01-01)

NLRP3 Inflammasome-Mediated Osteoarthritis: The Role of Epigenetics
by: Yuzhou Liu, et al.
Published: (2025-01-01)

Formononetin Administration Ameliorates Dextran Sulfate Sodium-Induced Acute Colitis by Inhibiting NLRP3 Inflammasome Signaling Pathway
by: Dacheng Wu, et al.
Published: (2018-01-01)

Iodine activates NLRP3 inflammasomes in PBMCs of patients with autoimmune thyroiditis and regulates Th1 and Th17 cell differentiation
by: Ying Wu, et al.
Published: (2025-01-01)

Pioglitazone Metformin Complex Improves Polycystic Ovary Syndrome Comorbid Psychological Distress via Inhibiting NLRP3 Inflammasome Activation: A Prospective Clinical Study
by: Qing-jun Guo, et al.
Published: (2020-01-01)

Protective mechanism of safflower yellow injection on myocardial ischemia-reperfusion injury in rats by activating NLRP3 inflammasome
by: Lingmei Li, et al.
Published: (2025-01-01)

Aronia melanocarpa Leaves as a Source of Chlorogenic Acids, Anthocyanins, and Sorbitol, and Their Anti-Inflammatory Activity
by: Agnieszka Zielińska, et al.
Published: (2020-12-01)

USP22 inhibits microglial M1 polarization by regulating the PU.1/NLRP3 inflammasome pathway
by: Ming-chen Yu, et al.
Published: (2025-01-01)

NPT1220-312, a TLR2/TLR9 Small Molecule Antagonist, Inhibits Pro-Inflammatory Signaling, Cytokine Release, and NLRP3 Inflammasome Activation
by: Agata Habas, et al.
Published: (2022-01-01)

The Antimalarial Chloroquine Suppresses LPS-Induced NLRP3 Inflammasome Activation and Confers Protection against Murine Endotoxic Shock
by: Xiaoli Chen, et al.
Published: (2017-01-01)

CD36-Mediated Lipid Accumulation and Activation of NLRP3 Inflammasome Lead to Podocyte Injury in Obesity-Related Glomerulopathy
by: Jing Zhao, et al.
Published: (2019-01-01)

Macropinocytosis enhances foamy macrophage formation and cholesterol crystallization to activate NLRP3 inflammasome after spinal cord injury
by: Chenxi Zhang, et al.
Published: (2025-02-01)

Lacticaseibacillus rhamnosus Fmb14 ameliorates hyperuricemia-induced hepatocyte pyroptosis via NLRP3 inflammasome cascade inhibition
by: Hongyuan Zhao, et al.
Published: (2024-07-01)

Inflammasome-targeted therapy for oral cancer: Highlighting NLRP3 inflammasome as a promising clinical therapeutic target
by: Geetha Shanmugam
Published: (2024-06-01)

Recent Advances of the NLRP3 Inflammasome in Central Nervous System Disorders
by: Keren Zhou, et al.
Published: (2016-01-01)

Targeting the NLRP3 inflammasome abrogates cardiotoxicity of immune checkpoint blockers
by: Ping Li, et al.
Published: (2025-01-01)

Corrigendum to “CD36-Mediated Lipid Accumulation and Activation of NLRP3 Inflammasome Lead to Podocyte Injury in Obesity-Related Glomerulopathy”
by: Jing Zhao, et al.
Published: (2019-01-01)